메뉴 건너뛰기




Volumn 17, Issue 29, 2010, Pages 3353-3357

Interleukin-18: Biology and role in the immunotherapy of cancer

Author keywords

Cytokine; Immunotherapy; Interferon ; Natural killer cell; Rituximab; T cell

Indexed keywords

DOXORUBICIN; GAMMA INTERFERON; IBOCTADEKIN; INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 18; RITUXIMAB;

EID: 77957945366     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710793176348     Document Type: Article
Times cited : (80)

References (54)
  • 1
    • 0014887939 scopus 로고
    • The concept of immune surveillance
    • Burnet, F.M. The concept of immune surveillance. Prog. Exp. Tumor Res., 1970, 13, 1-27.
    • (1970) Prog. Exp. Tumor Res , vol.13 , pp. 1-27
    • Burnet, F.M.1
  • 2
    • 77957945021 scopus 로고    scopus 로고
    • House, R.V.; Descotes, J., Eds.; Humana Press: Totowa, NJ
    • Robertson, M.J. In Cytokines in Human Health. House, R.V.; Descotes, J., Eds.; Humana Press: Totowa, NJ, 2007, pp 297-317.
    • (2007) Cytokines In Human Health , pp. 297-317
    • Robertson, M.J.1
  • 3
    • 11144299492 scopus 로고    scopus 로고
    • NK cell recognition
    • Lanier, L.L. NK cell recognition. Annu. Rev. Immunol., 2005, 23, 225-274.
    • (2005) Annu. Rev. Immunol , vol.23 , pp. 225-274
    • Lanier, L.L.1
  • 5
    • 0003732734 scopus 로고    scopus 로고
    • Janeway-Jr, C.A.; Travers, P.; Walport, M.; Shlomchik, M.J., Eds., 6th ed. Garland Science: New York
    • Janeway-Jr, C.A.; Travers, P.; Walport, M.; Shlomchik, M.J., Eds. Immunobiology: the immune system in health and disease. 6th ed. Garland Science: New York, 2005.
    • (2005) Immunobiology: The Immune System In Health and Disease
  • 6
    • 0004257938 scopus 로고    scopus 로고
    • Paul, W.E., Ed., 5th ed. Williams and Wilkin: Philadelphia
    • Paul, W.E., Ed. Fundamental Immunology. 5th ed. Williams and Wilkin: Philadelphia, 2003.
    • (2003) Fundamental Immunology
  • 7
    • 0028201732 scopus 로고
    • Tolerance, danger, and the extended family
    • Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol., 1994, 12, 991-1045.
    • (1994) Annu. Rev. Immunol. , vol.12 , pp. 991-1045
    • Matzinger, P.1
  • 9
  • 11
    • 0036467389 scopus 로고    scopus 로고
    • IL-1 and IL-18 receptors, and their extended family
    • Sims, J.E. IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol., 2002, 14, 117-122.
    • (2002) Curr. Opin. Immunol , vol.14 , pp. 117-122
    • Sims, J.E.1
  • 12
    • 62649139025 scopus 로고    scopus 로고
    • Immunological and inflammatory functions of the interleukin-1 family
    • Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol.,2009, 27, 519-550.
    • (2009) Annu. Rev. Immunol , vol.27 , pp. 519-550
    • Dinarello, C.A.1
  • 17
    • 8544275811 scopus 로고    scopus 로고
    • Interleukin-18: Recent advances
    • Reddy, P. Interleukin-18: recent advances. Curr. Opin. Hematol., 2004, 11, 405-410.
    • (2004) Curr. Opin. Hematol , vol.11 , pp. 405-410
    • Reddy, P.1
  • 18
    • 0030766468 scopus 로고    scopus 로고
    • Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma
    • Micallef, M.J.; Tanimoto, T.; Kohno, K.; Ikeda, M.; Kurimoto, M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res., 1997, 57, 4557-4563.
    • (1997) Cancer Res , vol.57 , pp. 4557-4563
    • Micallef, M.J.1    Tanimoto, T.2    Kohno, K.3    Ikeda, M.4    Kurimoto, M.5
  • 20
    • 2642674449 scopus 로고    scopus 로고
    • IFN-γ-inducing factor/IL-18 administration mediates IFN-γ-and IL-12-independent antitumor effects
    • Osaki, T.; Peron, J.-M.; Cai, Q.; Okamura, H.; Robbins, P.D.; Kurimoto, M.; Lotze, M.T.; Tahara, H. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects. J. Immunol., 1998, 160, 1742-1749.
    • (1998) J. Immunol. , vol.160 , pp. 1742-1749
    • Osaki, T.1    Peron, J.-M.2    Cai, Q.3    Okamura, H.4    Robbins, P.D.5    Kurimoto, M.6    Lotze, M.T.7    Tahara, H.8
  • 21
    • 0033565876 scopus 로고    scopus 로고
    • Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively
    • Hashimoto, W.; Osaki, T.; Okamura, H.; Robbins, P.D.; Kurimoto, M.; Nagata, S.; Peron, J.-M.; Lotze, M.T.; Tahara, H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J. Immunol., 1999, 163, 583-589.
    • (1999) J. Immunol , vol.163 , pp. 583-589
    • Hashimoto, W.1    Osaki, T.2    Okamura, H.3    Robbins, P.D.4    Kurimoto, M.5    Nagata, S.6    Peron, J.-M.7    Lotze, M.T.8    Tahara, H.9
  • 26
    • 0030067276 scopus 로고    scopus 로고
    • Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma
    • Wigginton, J.M.; Komschlies, K.L.; Back, T.C.; Franco, J.L.; Brunda, M.J.; Wiltrout, R.H. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst., 1996, 88, 38-43.
    • (1996) J. Natl. Cancer Inst , vol.88 , pp. 38-43
    • Wigginton, J.M.1    Komschlies, K.L.2    Back, T.C.3    Franco, J.L.4    Brunda, M.J.5    Wiltrout, R.H.6
  • 27
    • 0038176025 scopus 로고    scopus 로고
    • Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response
    • Son, Y.-I.; Dallal, R.M.; Lotze, M.T. Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response. J. Immunother., 2003, 26, 234-240.
    • (2003) J. Immunother , vol.26 , pp. 234-240
    • Son, Y.-I.1    Dallal, R.M.2    Lotze, M.T.3
  • 28
    • 0037370285 scopus 로고    scopus 로고
    • Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo
    • Redlinger Jr, R.E.; Mailliard, R.B.; Lotze, M.T.; Barksdale Jr, E.M. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo. J. Pediatr. Surg., 2003, 38, 301-307.
    • (2003) J. Pediatr. Surg , vol.38 , pp. 301-307
    • Redlinger, R.E.1    Mailliard, R.B.2    Lotze, M.T.3    Barksdale, E.M.4
  • 29
    • 0034663047 scopus 로고    scopus 로고
    • Coadminstration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: Critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction
    • Carson, W.E.; Dierksheide, J.E.; Jabbour, S.; Anghelina, M.; Bouchard, P.; Ku, G.; Yu, H.; Baumann, H.; Shah, M.H.; Cooper, M.A.; Durbin, J.; Caligiuri, M.A. Coadminstration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction. Blood, 2000, 96, 1465-1473.
    • (2000) Blood , vol.6 , pp. 1465-1473
    • Carson, W.E.1    Dierksheide, J.E.2    Jabbour, S.3    Anghelina, M.4    Bouchard, P.5    Ku, G.6    Yu, H.7    Baumann, H.8    Shah, M.H.9    Cooper, M.A.10    Durbin, J.11    Caligiuri, M.A.12
  • 30
    • 68949092271 scopus 로고    scopus 로고
    • Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity
    • Rodriguez-Galan, M.C.; Reynolds, D.; Correa, S.G.; Iribarren, P.; Watanabe, M.; Young, H.A. Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity. J. Immunol., 2009, 183, 740-748.
    • (2009) J. Immunol , vol.183 , pp. 740-748
    • Rodriguez-Galan, M.C.1    Reynolds, D.2    Correa, S.G.3    Iribarren, P.4    Watanabe, M.5    Young, H.A.6
  • 31
    • 0033539579 scopus 로고    scopus 로고
    • Synergistic inhibition of tumor growth in a murine mammary carcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1γ converting enzyme cDNA
    • Oshikawa, K.; Shi, F.; Rakhmilevich, A.L.; Sondel, P.M.; Mahvi, D.M.; Yang, N.-S. Synergistic inhibition of tumor growth in a murine mammary carcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1γ converting enzyme cDNA. Proc. Natl. Acad. Sci. USA, 1999, 96, 13351-13356.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 13351-13356
    • Oshikawa, K.1    Shi, F.2    Rakhmilevich, A.L.3    Sondel, P.M.4    Mahvi, D.M.5    Yang, N.-S.6
  • 33
    • 66149127280 scopus 로고    scopus 로고
    • Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis
    • Zheng, J.-N.; Pei, D.-S.; Mao, L.-J.; Liu, X.-Y.; Sun, F.-H.; Zhang, B.-F.; Liu, Y.-Q.; Liu, J.-J.; Li, W.; Han, D. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis. Cancer Biol. Ther., 2009, 8, 599-606.
    • (2009) Cancer Biol. Ther , vol.8 , pp. 599-606
    • Zheng, J.-N.1    Pei, D.-S.2    Mao, L.-J.3    Liu, X.-Y.4    Sun, F.-H.5    Zhang, B.-F.6    Liu, Y.-Q.7    Liu, J.-J.8    Li, W.9    Han, D.10
  • 34
    • 72449179439 scopus 로고    scopus 로고
    • Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis
    • Zheng, J.-N.; Pei, D.-S.; Mao, L.-J.; Liu, X.-Y.; Sun, F.-H.; Zhang, B.-F.; Liu, Y.-Q.; Liu, J.-J.; Li, W.; Han, D. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis. Cancer Gene Ther., 2010, 17, 28-36.
    • (2010) Cancer Gene Ther , vol.17 , pp. 28-36
    • Zheng, J.-N.1    Pei, D.-S.2    Mao, L.-J.3    Liu, X.-Y.4    Sun, F.-H.5    Zhang, B.-F.6    Liu, Y.-Q.7    Liu, J.-J.8    Li, W.9    Han, D.10
  • 36
    • 73249137169 scopus 로고    scopus 로고
    • Hammond, r.; Danet-Desnoyes, G.; June, C.H.; Powell Jr, D.J.; Coukos, G. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
    • Alagkiozidis, I.; Facciabene, A.; Carpenito, C.; Benencia, F.; Jonak, Z.; Adams, S.; Carroll, R.G.; Gimotty, P.A.; Hammond, r.; Danet-Desnoyes, G.; June, C.H.; Powell Jr, D.J.; Coukos, G. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. J. Translat. Med., 2009, 7, 104-112.
    • (2009) J. Translat. Med , vol.7 , pp. 104-112
    • Alagkiozidis, I.1    Facciabene, A.2    Carpenito, C.3    Benencia, F.4    Jonak, Z.5    Adams, S.6    Carroll, R.G.7    Gimotty, P.A.8
  • 38
    • 0036838671 scopus 로고    scopus 로고
    • Interleukin 18 preserves perforindependent graft-versus-leukemia effect after allogeneic bone marrow transplantation
    • Reddy, P.; Teshima, T.; Hildebrandt, G.; Duffner, U.; Maeda, Y.; Cooke, K.R.; Ferrara, J.L.M. Interleukin 18 preserves perforindependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood, 2002, 100, 3429-3431.
    • (2002) Blood , vol.100 , pp. 3429-3431
    • Reddy, P.1    Teshima, T.2    Hildebrandt, G.3    Duffner, U.4    Maeda, Y.5    Cooke, K.R.6    Ferrara, J.L.M.7
  • 39
    • 0035914735 scopus 로고    scopus 로고
    • Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis
    • Reddy, P.; Teshima, T.; Kukuruga, M.; Ordemann, R.; Liu, C.; Ferrara, J.L.M. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J. Exp. Med., 2001, 194, 1433-1440.
    • (2001) J. Exp. Med , vol.194 , pp. 1433-1440
    • Reddy, P.1    Teshima, T.2    Kukuruga, M.3    Ordemann, R.4    Liu, C.5    Ferrara, J.L.M.6
  • 40
    • 8644286385 scopus 로고    scopus 로고
    • Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation
    • Min, C.-K.; Maeda, Y.; Lowler, K.; Liu, C.; Clouthier, S.; Lofthus, D.; Weisiger, E.; Ferrara, J.L.M.; Reddy, P. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood, 2004, 104, 3393-3399.
    • (2004) Blood , vol.104 , pp. 3393-3399
    • Min, C.-K.1    Maeda, Y.2    Lowler, K.3    Liu, C.4    Clouthier, S.5    Lofthus, D.6    Weisiger, E.7    Ferrara, J.L.M.8    Reddy, P.9
  • 41
    • 0038784377 scopus 로고    scopus 로고
    • Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects
    • Reddy, P.; Teshima, T.; Hildebrandt, G.; Williams, D.L.; Cooke, K.R.; Ferrara, J.L.M. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood, 2003, 101, 2877-2885.
    • (2003) Blood , vol.101 , pp. 2877-2885
    • Reddy, P.1    Teshima, T.2    Hildebrandt, G.3    Williams, D.L.4    Cooke, K.R.5    Ferrara, J.L.M.6
  • 44
    • 0036847429 scopus 로고    scopus 로고
    • Interleukin-12 immunotherapy after autologous stem cell transplantation for hematologic malignancies
    • Robertson, M.J.; Pelloso, D.; Abonour, R.; Hromas, R.A.; Nelson Jr, R.P.; Wood, L.; Cornetta, K. Interleukin-12 immunotherapy after autologous stem cell transplantation for hematologic malignancies. Clin. Cancer Res., 2002, 8, 3383-3393.
    • (2002) Clin. Cancer Res , vol.8 , pp. 3383-3393
    • Robertson, M.J.1    Pelloso, D.2    Abonour, R.3    Hromas, R.A.4    Nelson, R.P.5    Wood, L.6    Cornetta, K.7
  • 45
    • 1642303259 scopus 로고    scopus 로고
    • Immunological consequences of interleukin 12 administration after autologous stem cell transplantation
    • Pelloso, D.; Cyran, K.; Timmons, L.; Williams, B.T.; Robertson, M.J. Immunological consequences of interleukin 12 administration after autologous stem cell transplantation. Clin. Cancer Res., 2004, 10, 1935-1942.
    • (2004) Clin. Cancer Res , vol.10 , pp. 1935-1942
    • Pelloso, D.1    Cyran, K.2    Timmons, L.3    Williams, B.T.4    Robertson, M.J.5
  • 46
    • 23044498580 scopus 로고    scopus 로고
    • Impaired interferon-γ production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma
    • Robertson, M.J.; Chang, H.-C.; Pelloso, D.; Kaplan, M.H. Impaired interferon-γ production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma. Blood, 2005, 106, 963-970.
    • (2005) Blood , vol.106 , pp. 963-970
    • Robertson, M.J.1    Chang, H.-C.2    Pelloso, D.3    Kaplan, M.H.4
  • 47
    • 67651097885 scopus 로고    scopus 로고
    • Impaired development of human Th1 cells in patients with deficient expression of STAT4
    • Chang, H.-C.; Han, L.; Goswami, R.; Nguyen, E.T.; Pelloso, D.; Robertson, M.J.; Kaplan, M.H. Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood, 2009, 113, 5887-5890.
    • (2009) Blood , vol.113 , pp. 5887-5890
    • Chang, H.-C.1    Han, L.2    Goswami, R.3    Nguyen, E.T.4    Pelloso, D.5    Robertson, M.J.6    Kaplan, M.H.7
  • 48
    • 0034254177 scopus 로고    scopus 로고
    • The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression
    • Zhang, S.; Kaplan, M.H. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J. Immunol., 2000, 165, 1375-1380.
    • (2000) J. Immunol. , vol.165 , pp. 1375-1380
    • Zhang, S.1    Kaplan, M.H.2
  • 52
    • 68549131676 scopus 로고    scopus 로고
    • Phase I dose escalation study to assess tolerability and pharmcokinetics of recombinant human interleukin-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors
    • abstract 2591
    • Lewis, N.; Gollob, J.; Cohen, R.; Thoreson, M.; Oei, C.; Kirby, L.; Koch, K.; Thurmond, L.; Dar, M.; Bell, W. Phase I dose escalation study to assess tolerability and pharmcokinetics of recombinant human interleukin-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors. J. Clin. Oncol., 2004, 22, 185s (abstract 2591).
    • (2004) J. Clin. Oncol , vol.22
    • Lewis, N.1    Gollob, J.2    Cohen, R.3    Thoreson, M.4    Oei, C.5    Kirby, L.6    Koch, K.7    Thurmond, L.8    Dar, M.9    Bell, W.10
  • 54
    • 85036758302 scopus 로고    scopus 로고
    • A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ Bcell non-Hodgkin's lymphoma
    • abstract 8566
    • Robertson, M.J.; Kline, J.; Bauman, J.; Gardner, O.; Jonak, Z.; Koch, K. M.; Murray, S.C.; Weisenbach, J.; Toso, J. A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ Bcell non-Hodgkin's lymphoma. J. Clin. Oncol., 2009, 27, 450s (abstract 8566).
    • (2009) J. Clin. Oncol , vol.27
    • Robertson, M.J.1    Kline, J.2    Bauman, J.3    Gardner, O.4    Jonak, Z.5    Koch, K.M.6    Murray, S.C.7    Weisenbach, J.8    Toso, J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.